PP2231 - Human Pathophysiology and Pharmacology 2
| Credit points: | 03 |
| Year: | 2019 |
| Student Contribution Band: | Band 2 |
| Administered by: |
Available to Nursing Science students only.
This subject extends the students' knowledge of pathophysiology and pharmacology in relation to health and disease. Students will explore alterations in nervous, gastrointestinal, reproductive and endocrine function, as well as their respective drug treatments. Concepts in Neoplasia pathophysiology and the treatment strategies is also covered.
Learning Outcomes
- describe the major functions of nervous system, endocrine glands, reproductive organs and gastrointestinal tract;
- apply knowledge of pathophysiology of traumatic brain injury and acute disorders of brain function to explain resultant functional and cognitive changes;
- use knowledge of common acquired and congenital endocrine disorders to explain alterations in growth, reproductive function, metabolism, electrolyte balance and blood glucose levels;
- identify the clinical signs associated with injury to or disorders of the endocrine, reproductive, gastrointestinal and central nervous systems and state pharmacological and non-pharmacological approaches for treating these pathologic conditions;
- relate knowledge of pathophysiology of common neoplasia to the major neoplasia treatment modalities explaining the role of radiation and nuclear medicine technology in the treatment of neoplasia;
- describe how common disorders of the gastrointestinal system affect secretion, motility, nutrient and electrolyte absorption and liver function.
| Prerequisites: | BM1011 and BM1022 |
Availabilities | |
| , Study Period 2 | |
| Census Date 29-Aug-2019 | |
| Contact hours: |
|
| Method of Delivery: | WWW - LearnJCU |
| Assessment: | other exams (60%); on course non-invigilated assessment (40%). |
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.